Continous Blood Glucose Monitoring Global Market Report 2023

Description

“Continous Blood Glucose Monitoring Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continous blood glucose monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continous blood glucose monitoring? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The continous blood glucose monitoring market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

* The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

* The impact of higher inflation in many countries and the resulting spike in interest rates.

* The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Component: Insulin Pumps; Sensors; Transmitters; Receivers

2) By Application: Type 1 Diabetic Patients; Type 2 Diabetic Patients; Gestational Diabetes; Critical Care Patients

3) By End User: Hospitals; Homecare Diagnostics; Other End Users

Companies Mentioned: Roche; Lifescan; Medtronic; Abbott; GlySens Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the continuous blood glucose monitoring market are: Roche, Lifescan, Medtronic, Abbott, GlySens Inc., Arkray, Senseonics Holdings Inc., Glysure limited, Nemaura, Tandem Diabetes Care, Goldsite Diagonostics Inc., AgaMatrix Inc., B. Braun Melsungen, Ypsomed Holding AG, Terumo, and Orsense ltd.

The global continuous blood glucose monitoring market grew from $11.19 billion in 2022 to $12.5 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The continuous blood glucose monitoring market is expected to grow to $18.83 billion in 2027 at a CAGR of 10.8%.

The continuous blood glucose monitoring market consists of sales of real-time continuous glucose monitoring, and intermittently scanned continuous glucose monitoring. Values in this market are: 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

A continuous blood glucose monitoring device enables a person to better regulate glucose levels throughout the day and to experience fewer low blood glucose situations.

North America was the largest region in the continuous blood glucose monitoring market in 2022. The regions covered in the continuous blood glucose monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of components in continuous blood glucose monitoring devices are insulin pumps, sensors, transmitters, and receivers. Insulin pumps are small, computerized devices designed and programmed to deliver pre-determined doses of insulin in diabetic patients at specific intervals. These devices are used by type 1 diabetic patients, type 2 diabetic patients, gestational diabetes, and critical care patients which are used by various end-users, including hospitals, homecare diagnostics, and other end users.

The increasing prevalence of diabetes is expected to propel the growth of the continuous blood glucose monitoring market going forward. Diabetes is a health disease that occurs when the blood glucose levels fluctuate in the body. Blood glucose monitoring devices can aid in the detection of trends and patterns that give a better full picture of a diabetic's condition. For instance, according to the International Diabetes Federation, in 2020, around 463 million adults were affected by diabetes, among which 10.0% of them had type 1 diabetes, and 90.0% had type 2 diabetes. Therefore, the increasing prevalence of diabetes is driving the growth of the continuous blood glucose monitoring market.

Technological advancements have emerged as a key trend gaining popularity in the continuous blood glucose monitoring market. Major companies operating in the continuous blood glucose monitoring market are focused on developing advanced technological solutions to strengthen their position in the market. For instance, in 2020, Philips, a Netherlands-based health technology company that manufactures glucose monitoring devices launched non-invasive monitors for COPD patients based on ExpiraFlow technology. The non-invasive monitors help health care professionals to detect and screen the expiratory flow limitation and can also be used in optimal home care therapy.

In August 2020, Medtronic PLC., an Ireland-based medical device company, acquired Companion Medical for an undisclosed amount. The acquisition is intended to allow Medtronic PLC. to extend its product line and provide people with a one-of-a-kind and expansive ecosystem of support for their diabetes. Companion Medical Inc. is a US-based company that manufactures smart insulin pens which are used to monitor blood glucose.

The countries covered in the continuous blood glucose monitoring market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The continuous blood glucose monitoring market research report is one of a series of new reports from The Business Research Company that provides continuous blood glucose monitoring market statistics, including continuous blood glucose monitoring industry global market size, regional shares, competitors with a continuous blood glucose monitoring market share, detailed continuous blood glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous blood glucose monitoring industry. This continuous blood glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Product Code: r3357

1. Executive Summary

2. Continuous Blood Glucose Monitoring Market Characteristics

3. Continuous Blood Glucose Monitoring Market Trends And Strategies

4. Continuous Blood Glucose Monitoring Market - Macro Economic Scenario

4.1. COVID-19 Impact On Continuous Blood Glucose Monitoring Market
4.2. Ukraine-Russia War Impact On Continuous Blood Glucose Monitoring Market
4.3. Impact Of High Inflation On Continuous Blood Glucose Monitoring Market

5. Continuous Blood Glucose Monitoring Market Size And Growth

5.1. Global Continuous Blood Glucose Monitoring Historic Market, 2017-2022, $ Billion
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints On The Market
5.2. Global Continuous Blood Glucose Monitoring Forecast Market, 2022-2027F, 2032F, $ Billion
- 5.2.1. Drivers Of The Market
- 5.2.2. Restraints On the Market

6. Continuous Blood Glucose Monitoring Market Segmentation

6.1. Global Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Insulin Pumps
Sensors
Transmitters
Receivers
6.2. Global Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Type 1 Diabetic Patients
Type 2 Diabetic Patients
Gestational Diabetes
Critical Care Patients
6.3. Global Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospitals
Homecare Diagnostics
Other End Users

7. Continuous Blood Glucose Monitoring Market Regional And Country Analysis

7.1. Global Continuous Blood Glucose Monitoring Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Continuous Blood Glucose Monitoring Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Continuous Blood Glucose Monitoring Market

8.1. Asia-Pacific Continuous Blood Glucose Monitoring Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Continuous Blood Glucose Monitoring Market

9.1. China Continuous Blood Glucose Monitoring Market Overview
9.2. China Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Continuous Blood Glucose Monitoring Market

10.1. India Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Continuous Blood Glucose Monitoring Market

11.1. Japan Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Continuous Blood Glucose Monitoring Market

12.1. Australia Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Continuous Blood Glucose Monitoring Market

13.1. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Continuous Blood Glucose Monitoring Market

14.1. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Continuous Blood Glucose Monitoring Market

15.1. Western Europe Continuous Blood Glucose Monitoring Market Overview
15.2. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Continuous Blood Glucose Monitoring Market

16.1. UK Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Continuous Blood Glucose Monitoring Market

17.1. Germany Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Continuous Blood Glucose Monitoring Market

18.1. France Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Continuous Blood Glucose Monitoring Market

19.1. Eastern Europe Continuous Blood Glucose Monitoring Market Overview
19.2. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Continuous Blood Glucose Monitoring Market

20.1. Russia Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Continuous Blood Glucose Monitoring Market

21.1. North America Continuous Blood Glucose Monitoring Market Overview
21.2. North America Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Continuous Blood Glucose Monitoring Market

22.1. USA Continuous Blood Glucose Monitoring Market Overview
22.2. USA Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Continuous Blood Glucose Monitoring Market

23.1. South America Continuous Blood Glucose Monitoring Market Overview
23.2. South America Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Continuous Blood Glucose Monitoring Market

24.1. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Continuous Blood Glucose Monitoring Market

25.1. Middle East Continuous Blood Glucose Monitoring Market Overview
25.2. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Continuous Blood Glucose Monitoring Market

26.1. Africa Continuous Blood Glucose Monitoring Market Overview
26.2. Africa Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Continuous Blood Glucose Monitoring Market Competitive Landscape And Company Profiles

27.1. Continuous Blood Glucose Monitoring Market Competitive Landscape
27.2. Continuous Blood Glucose Monitoring Market Company Profiles
- 27.2.1. Roche
  - 27.2.1.1. Overview
  - 27.2.1.2. Products and Services
  - 27.2.1.3. Strategy
  - 27.2.1.4. Financial Performance
- 27.2.2. Lifescan
  - 27.2.2.1. Overview
  - 27.2.2.2. Products and Services
  - 27.2.2.3. Strategy
  - 27.2.2.4. Financial Performance
- 27.2.3. Medtronic
  - 27.2.3.1. Overview
  - 27.2.3.2. Products and Services
  - 27.2.3.3. Strategy
  - 27.2.3.4. Financial Performance
- 27.2.4. Abbott
  - 27.2.4.1. Overview
  - 27.2.4.2. Products and Services
  - 27.2.4.3. Strategy
  - 27.2.4.4. Financial Performance
- 27.2.5. GlySens Inc.
  - 27.2.5.1. Overview
  - 27.2.5.2. Products and Services
  - 27.2.5.3. Strategy
  - 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Continuous Blood Glucose Monitoring Market

29. Continuous Blood Glucose Monitoring Market Future Outlook and Potential Analysis

30. Appendix

30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. The Business Research Company
30.6. Copyright And Disclaimer